VEGF anticorps (N-Term)
Aperçu rapide pour VEGF anticorps (N-Term) (ABIN2384453)
Antigène
Voir toutes VEGF AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 33-48, N-Term
-
Séquence
- VDIFQEYPDE IEYIFK
-
Réactivité croisée
- Humain, Rat (Rattus)
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu Rt
-
Attributs du produit
- Vascular Endothelial Growth Factor (VEGF-A, Vascular Permeability Factor, VPF, VEGFA, VEGF)
-
Purification
- Purified by immunoaffinity chromatography.
-
Immunogène
- Synthetic peptide corresponding to aa33-48, VDIFQEYPDEIEYIFK, sequence at the N-terminal of human Vascular Endothelial Growth Factor. Species Sequence Homology: Mouse
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Reconstitute with 100 μL sterile ddH2O.
-
Buffer
- Supplied as a lyophilized powder in 5 mg BSA, 0.9 mg sodium chloride, 0.2 mg Na2HPO4, 0.05 mg Thimerosal, 0.05 mg sodium azide.
-
Agent conservateur
- Sodium azide, Thimerosal (Merthiolate)
-
Précaution d'utilisation
- This product contains Sodium azide and Thimerosal (Merthiolate): POISONOUS AND HAZARDOUS SUBSTANCES which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- -20°C
-
-
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
Autre désignation
- Vascular Endothelial Growth Factor
-
UniProt
- P15692
Antigène
-